Müller OJ - Search Results

1

Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.

Kuhn TC, Knobel J, Burkert-Rettenmaier S, Li X, Meyer IS, Jungmann A, Sicklinger F, Backs J, Lasitschka F, Müller OJ, Katus HA, Krijgsveld J, Leuschner F. Kuhn TC, et al. Among authors: muller oj. Circulation. 2020 May 19;141(20):1628-1644. doi: 10.1161/CIRCULATIONAHA.119.044914. Epub 2020 Feb 26. Circulation. 2020. PMID: 32100557

2

[A transgenic animal model: new possibilities for cardiovascular research].

Franz WM, Frey N, Müller O, Kübler W, Katus HA. Franz WM, et al. Z Kardiol. 1995;84 Suppl 4:17-32. Z Kardiol. 1995. PMID: 8585270 Review. German.

3

Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias.

Frey N, Franz WM, Gloeckner K, Degenhardt M, Müller M, Müller O, Merz H, Katus HA. Frey N, et al. Cardiovasc Res. 2000 Aug;47(2):254-64. doi: 10.1016/s0008-6363(00)00114-0. Cardiovasc Res. 2000. PMID: 10946062

4

Selection of ventricular-like cardiomyocytes from ES cells in vitro.

Müller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, Müller OJ, Schlenke P, Frese S, Wobus AM, Hescheler J, Katus HA, Franz WM. Müller M, et al. Among authors: muller oj. FASEB J. 2000 Dec;14(15):2540-8. doi: 10.1096/fj.00-0002com. FASEB J. 2000. PMID: 11099473

5

Cardiomyopathies: from genetics to the prospect of treatment.

Franz WM, Müller OJ, Katus HA. Franz WM, et al. Among authors: muller oj. Lancet. 2001 Nov 10;358(9293):1627-37. doi: 10.1016/S0140-6736(01)06657-0. Lancet. 2001. PMID: 11716909 Review.

6

Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload.

Müller OJ, Lange M, Rattunde H, Lorenzen HP, Müller M, Frey N, Bittner C, Simonides W, Katus HA, Franz WM. Müller OJ, et al. Among authors: muller m. Cardiovasc Res. 2003 Aug 1;59(2):380-9. doi: 10.1016/s0008-6363(03)00429-2. Cardiovasc Res. 2003. PMID: 12909321

7

S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.

Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Müller OJ, Eckhart AD, Katus HA, Koch WJ, Most P. Pleger ST, et al. Among authors: muller oj. Mol Ther. 2005 Dec;12(6):1120-9. doi: 10.1016/j.ymthe.2005.08.002. Epub 2005 Sep 15. Mol Ther. 2005. PMID: 16168714 Free article.

8

Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.

Müller OJ, Leuchs B, Pleger ST, Grimm D, Franz WM, Katus HA, Kleinschmidt JA. Müller OJ, et al. Cardiovasc Res. 2006 Apr 1;70(1):70-8. doi: 10.1016/j.cardiores.2005.12.017. Epub 2006 Jan 31. Cardiovasc Res. 2006. PMID: 16448634

9

Identification of a 94-bp GC-rich element in the smooth muscle myosin heavy-chain promoter controlling vascular smooth muscle cell-specific gene expression.

Deindl E, Middeler G, Müller OJ, Selbert S, Schlenke P, Marienfeld U, Thirion C, Katus HA, Franz WM. Deindl E, et al. Among authors: muller oj. Cell Biochem Biophys. 2006;45(3):279-88. doi: 10.1385/CBB:45:3:279. Cell Biochem Biophys. 2006. PMID: 16845174

10

Targeting the heart with gene therapy-optimized gene delivery methods.

Müller OJ, Katus HA, Bekeredjian R. Müller OJ, et al. Cardiovasc Res. 2007 Feb 1;73(3):453-62. doi: 10.1016/j.cardiores.2006.09.021. Epub 2006 Oct 3. Cardiovasc Res. 2007. PMID: 17097076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page